Thomas J. Guzzo MD, MPHChief of Urology and Associate Program Director, University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania
Dr. Guzzo is Chief of Urology and Associate Program Director at the University of Pennsylvania. He is a graduate of Temple University School of Medicine. He completed his general surgery internship and urology residency at the Hospital of the University of Pennsylvania. Dr. Guzzo completed a fellowship at the James Buchanan Brady Urological Institute of the Johns Hopkins Hospital in urologic oncology. During his fellowship he also earned a Masters in Public Health from the Johns Hopkins Bloomberg School of Public Health. He is extensively trained in the treatment of all aspects of urologic malignancies including open, laparoscopic, endoscopic and robotic surgical treatment for such malignancies.
Dr. Guzzo’s clinical areas of expertise include the surgical treatment of prostate, bladder, kidney and testicular cancer. He has one of the largest urologic oncology practices in the region and specializes in open, endoscopic and minimally invasive surgical procedures. Additionally, He is a member of the Penn Academy of master clinicians.
Dr. Guzzo also maintains a productive urologic oncology research program. He is a Prostate Cancer Foundation young investigator award recipient. He is the director of the urologic oncology research laboratory at the University of Pennsylvania. He has published over 120 peer-reviewed manuscripts, over a dozen book chapters and is the editor of two text books in urology.
DisclosuresNo disclosures to report.
Recent Contributions to PracticeUpdate:
- Lymph Node Metastases and Survival Outcome With Targeted Therapies
- Predicting High-Grade Cancer Using Four Kallikrein Markers
- Chemohormonal Therapy in Hormone-Sensitive Prostate Cancer
- Recurrence Patterns After Open and Robot-Assisted Radical Cystectomy
- Prostate Cancer, Comorbidity, and Risk for VTE
- Cardiovascular Mortality and Exposure to Androgen Deprivation Therapy
- Urinary Complications From Metastatic Prostate Cancer
- Cystoscopy Findings Following Neoadjuvant Chemotherapy for Bladder Cancer
- Aggressive Therapy for an Aggressive Disease: Treatment and Outcomes in Micropapillary Bladder Cancer
- Factors Associated With Worse Outcomes From Salvage Prostatectomy